Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
pembrolizumab
×
Clear all
Filters
2
NCT04387461
2024-09-25
CORE-001
CG Oncology, Inc.
Phase 2
Completed
35 enrolled